Trevi Therapeutics announces positive results for Haduvio in Phase 2b CORAL study

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, has reported a positive outcome from the planned sample size re-estimation (SSRE) for its ongoing Phase 2b trial. ... Read More